title: Oral anticoagulants: the move beyond warfarin.
authors.affiliation: Questions or comments about this article may be directed to Judith Frei, MSN RN CNE, at judith_frei@rush.edu. She is an Instructor, Rush University College of Nursing, Chicago, IL. V. Susan Carroll, MS RN-BC, is Clinical Nurse Educator, Neurosciences, Rush University Medical Center, Chicago, IL.
authors.forename: Judith
authors.initials: J
authors.lastname: Frei
authors.forename: V Susan
authors.initials: VS
authors.lastname: Carroll
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D001562:Benzimidazoles / Q000008:administration & dosage / Q000009:adverse effects; D000069604:Dabigatran; D017277:Drug Approval; D006801:Humans; D009025:Morpholines / Q000008:administration & dosage / Q000009:adverse effects; D011720:Pyrazoles / Q000008:administration & dosage / Q000009:adverse effects; D011728:Pyridones / Q000008:administration & dosage / Q000009:adverse effects; D000069552:Rivaroxaban; D013876:Thiophenes / Q000008:administration & dosage / Q000009:adverse effects; D013927:Thrombosis / Q000451:nursing* / Q000517:prevention & control*; D014859:Warfarin / Q000008:administration & dosage* / Q000009:adverse effects; D015091:beta-Alanine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D009025:Morpholines; D011720:Pyrazoles; D011728:Pyridones; D013876:Thiophenes; D015091:beta-Alanine; C522181:apixaban; D014859:Warfarin; D000069552:Rivaroxaban; D000069604:Dabigatran